Agios Pharmaceuticals | رأس المال والاحتياطيات



Equity Capital And Reserves تغيير تاريخ
AbbVie USD 1.46B 1.86B 2025-03
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 250.59M 135.16M 2025-06
Amgen USD 6.21B 330M 2025-03
Arrowhead Research USD 684.22M 631.64M 2025-03
Astellas Pharma JPY 1.48T 31.46B 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Bayer EUR 32.58B 537M 2025-03
Biogen USD 17.63B 655.3M 2025-06
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Daiichi Sankyo JPY 1.58T 44.86B 2025-06
Eli Lilly USD 15.85B 1.65B 2025-03
Exelixis USD 2.03B 97.49M 2025-07
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.35B 197M 2025-06
Incyte USD 4.17B 503.34M 2025-06
Ionis Pharmaceuticals USD 631.72M 156M 2025-06
Merck USD 48.34B 2.02B 2025-03
Moderna USD 10.07B 835M 2025-03
Novartis USD 42.05B 3.6B 2025-06
Novartis USD 44.05B 729M 2024-12
Pfizer USD 90.34B 2.14B 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12


Agios Pharmaceuticals رأس المال والاحتياطيات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.